From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...
Parkinson's disease, a degenerative brain condition primarily marked by the loss of muscle control, has been thrust into the media over the years in film and television. But there's still a ton of ...
Changes in the bacteria found in the mouth and gut of Parkinson’s disease patients could act as an early warning sign that their symptoms are worsening, new research suggests. Scientists, using ...
Neuropacs™ Corp., a leader in AI‑powered neurodiagnostics, today announced the publication of a seminal study co-authored by David Vaillancourt, PhD, the company’s Co‑Founder and Chief Scientific ...
Up to 1 in 3 people with Parkinson's disease use at least one psychotropic medication, a recent study from the University of Eastern Finland shows. People with Parkinson's disease were using ...
The Phase 2b LUMA study of BIIB122 in early-stage Parkinson’s disease did not meet its primary or secondary endpoints Based on data from the ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today its decision to proceed with Phase III development of prasinezumab, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results